TORONTO, Oct. 25,
2022 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX:
DHT.U) ("DRI" or "the Trust") announced today it will hold a
conference call to discuss its third quarter 2022 financial results
on Tuesday, November 8, 2022, at
8:00 a.m. ET. The Trust will report
its financial results on Monday, November 7,
2022, after market close.
All interested parties may join the conference call by dialing
416-764-8659 or 1-888-664-6392 approximately 15 minutes prior to
the call to secure a line. You will be put on hold until the
conference call begins. A question-and-answer session will follow
the conference call, at which time the operator will provide
instructions for submitting questions.
A live webcast of the conference call, including a slide
presentation, will be available through https://bit.ly/DRIQ32022.
Please connect at least 15 minutes prior to the conference call to
ensure adequate time for any software download that may be required
to join the webcast. The webcast will be archived on the Trust's
website following the call date.
About DRI Healthcare Trust
DRI Healthcare Trust is managed by DRI Capital Inc. ("DRI
Capital"), the pioneer in global pharmaceutical royalty
monetization with a more than 30-year history of accelerating
innovation by providing capital to inventors, academic institutions
and biopharma companies. Since our founding in 1989, DRI Capital
has deployed more than US$2 billion,
acquiring more than 60 royalties on 40-plus drugs, including Eylea,
Spinraza, Zytiga, Remicade, Keytruda and Stelara. DRI Healthcare
Trust's units are listed and trade on the Toronto Stock Exchange in
Canadian dollars under the symbol "DHT.UN" and in US dollars under
the symbol "DHT.U". To learn more, visit drihealthcaretrust.com or
follow us on LinkedIn.
SOURCE DRI Healthcare Trust